Index of reports
> Disability (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Aralen (Chloroquine) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Aralen side effects in 53 year old female
Reported by a consumer/non-health professional from Mexico on 2012-04-11
Patient: 53 year old female, weighing 71.0 kg (156.2 pounds)
Reactions: Cataract, Anaemia, Vision Blurred
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Aralen
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2008-01-01
Deflazacort
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2008-01-01
Arava
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2008-01-01
Methotrexate
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2007-01-01
Possible Aralen side effects in 53 year old female
Reported by a consumer/non-health professional from Mexico on 2012-03-23
Patient: 53 year old female, weighing 71.0 kg (156.2 pounds)
Reactions: Cataract, Anaemia, Vision Blurred
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Deflazacort
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2008-01-01
Methotrexate
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2007-01-01
Arava
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2008-01-01
Aralen
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2008-01-01
|